Clinical Trial

Measurement of Head and Neck Tumor Hypoxia With PET-MRI

Study acronym: EF5NECK
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated February 18, 2022 (before its estimated May 2026 completion). Its status may not reflect the trial's current state.
Summary
This study is designed to evaluate the performance of advanced magnetic resonance (MR) imaging in the assessment of tumor hypoxia using \[18F\]EF5 positron emission tomography (PET) as a reference in head and neck cancer patients. Low oxygen level or hypoxia contributes to radiotherapy resistance. Therefore, a clinically applicable method to detect tumor hypoxia is of great importance.
Trial Details
NCT Number NCT05246475
Lead Sponsor Turku University Hospital
Conditions Head and Neck Cancer
Enrollment 30 participants
Start Date 2022-02-08
Primary Completion 2026-05 (estimated)
Study Completion 2026-10 (estimated)
Updated on ClinicalTrials.gov 2022-02-18